Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Dolby Laboratories, Inc.DLB · Entity 2518 | EVP, Gen. Counsel & Secretary | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Dolby Laboratories, Inc.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 119,024 |
Reported balance
After 2026-09-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 48,076 · Balance 119,024 F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Award represents a total of 48,076 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Under the terms of the restricted stock unit grant agreement, 100% of the units shall vest on September 15, 2028, subject to the Reporting Person continuing to be a service provider through such date. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting.
F2: Shares held following the reported transactions include 101,712 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
F3: Shares include 385 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 19,518 | $65.09 | $1,270,451.99 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,179 F4 · price: The shares were sold in multiple transactions at prices ranging from $65.03 to $65.20, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 19,518 | $33.15 | $647,021.70 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,919 | $65.01 | $189,758.35 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,179 F3 · price: The shares were sold in multiple transactions at prices ranging from $65.00 to $65.03, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 2,919 | $30.49 | $89,000.31 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,098 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| February 21, 2019 Filed Feb 25, 2019 19:08 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,764 | $64.99 | $114,640.07 |
DisclosureSEC source: 0001209191-19-013222 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,179 F1 · price: The shares were sold in multiple transactions at prices ranging from $64.88 to $65.11, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Shares held following the reported transactions include 33,125 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 400 | $65.15 | $26,061.56 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,943 F6 · price: The shares were sold in multiple transactions at prices ranging from $65.10 to $65.22, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F4 · balance_after: Shares held following the reported transactions include 33,125 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 4,326 | $64.49 | $279,001.04 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,343 F5 · price: The shares were sold in multiple transactions at prices ranging from $64.10 to $65.06, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F4 · balance_after: Shares held following the reported transactions include 33,125 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 52,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,000 Underlying: Class A Common Stock · 52,000 shares Expires 2028-12-17 F8 · derivative.exercise_date: This option was granted for a total of 52,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 17, 2018, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $64.60 | $0.00 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · derivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Underlying: Class A Common Stock · 26,000 shares Expires 2025-12-17 F7 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 17, 2018 and ending December 17, 2021. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 13,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,669 F3 · acquired: Award represents a total of 13,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 17, 2018. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F4 · balance_after: Shares held following the reported transactions include 33,125 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 20:03 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 6,387 | $66.17 | $422,627.79 |
DisclosureSEC source: 0001209191-18-063595 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,669 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 20,125 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 16:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-18-048494 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,919 Underlying: Class A Common Stock · 10,000 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 16:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,000 | $70.00 | $700,000.00 |
DisclosureSEC source: 0001209191-18-048494 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,056 F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 16:22 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,000 | $30.49 | $304,900.00 |
DisclosureSEC source: 0001209191-18-048494 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest F2 · balance_after: Shares include 490 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2018. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 20:49 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-18-014304 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,919 Underlying: Class A Common Stock · 10,000 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 20:49 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,000 | $65.00 | $650,000.00 |
DisclosureSEC source: 0001209191-18-014304 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,566 F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 20:49 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,000 | $30.49 | $304,900.00 |
DisclosureSEC source: 0001209191-18-014304 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 31,554 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · derivative · entry 14 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,919 Underlying: Class A Common Stock · 31,554 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 500 | $63.05 | $31,525.00 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 11 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,566 F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 3,254 | $62.17 | $202,306.06 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 10 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,066 F7 · price: This transaction was executed in multiple trades at prices ranging from $61.97 to $62.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 18,000 | $61.56 | $1,107,993.60 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 9 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,320 F6 · price: This transaction was executed in multiple trades at prices ranging from $60.97 to $61.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 9,800 | $60.44 | $592,273.78 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 8 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,320 F5 · price: This transaction was executed in multiple trades at prices ranging from $59.97 to $60.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 08, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 31,554 | $30.49 | $962,081.46 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,227 | $0.00 Strike: $30.49 | $0.00 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · derivative · entry 13 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,473 Underlying: Class A Common Stock · 7,227 shares Expires 2022-12-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: This option was granted for a total of 61,700 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 21, 2012, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 41,219 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · derivative · entry 12 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 41,219 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,227 | $63.20 | $456,746.40 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,566 F4 · price: This transaction was executed in multiple trades at prices ranging from $62.68 to $63.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,227 | $30.49 | $220,351.23 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,401 | $63.67 | $471,239.43 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,566 F3 · price: This transaction was executed in multiple trades at prices ranging from $63.57 to $63.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 33,818 | $63.24 | $2,138,582.68 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,967 F2 · price: This transaction was executed in multiple trades at prices ranging from $62.5701 to $63.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 41,219 | $28.24 | $1,164,024.56 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| February 07, 2018 Filed Feb 9, 2018 20:23 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,554 | $63.10 | $98,057.40 |
DisclosureSEC source: 0001209191-18-009028 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,566 F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 18:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-18-003689 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,219 Underlying: Class A Common Stock · 10,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 18:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 10,000 | $65.00 | $650,000.00 |
DisclosureSEC source: 0001209191-18-003689 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,120 F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| January 12, 2018 Filed Jan 16, 2018 18:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 10,000 | $28.24 | $282,400.00 |
DisclosureSEC source: 0001209191-18-003689 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 33,002 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 19, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 1,665 | $62.22 | $103,590.97 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · nonDerivative · entry 5 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,120 F8 · price: The shares were sold in multiple transactions at prices ranging from $62 to $62.41, inclusive. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 33,002 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 2,929 | $62.58 | $183,296.23 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · nonDerivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,785 F7 · price: This transaction was executed in multiple trades at prices ranging from $62.21 to $62.93. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F6 · balance_after: Shares held following the reported transactions include 33,002 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 18, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 1,817 | $62.32 | $113,235.44 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,714 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F6 · balance_after: Shares held following the reported transactions include 33,002 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantEmployee Stock Option (Right to Buy) · Derivative | 56,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · derivative · entry 7 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,000 Underlying: Class A Common Stock · 56,000 shares Expires 2027-12-15 F10 · derivative.exercise_date: This option was granted for a total of 56,000 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 15, 2017, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantPerformance-Based Stock Option (Right to Buy) · Derivative | 28,000 | $0.00 Strike: $62.32 | $0.00 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · derivative · entry 6 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Class A Common Stock · 28,000 shares Expires 2024-12-15 F9 · derivative.exercise_date: The vesting of this performance-based stock option ("PSO") award is dependent upon achievement of performance criteria measured during a three-year performance period beginning on December 15, 2017 and ending December 15, 2020. The number of shares reported is at the target award amount. The reporting person may potentially earn from 0% to 125% of the target award amount based on total shareholder return at the end of the three-year performance period. The actual PSO award earned shall vest immediately upon certification by the Company's Compensation Committee of the achievement of the performance criteria, following the end of the three-year performance period. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | GrantClass A Common Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,531 F4 · acquired: Award represents a total of 14,000 restricted stock units granted under the terms of the Issuer's 2005 Stock Plan. Under the terms of the restricted stock unit grant agreement, 1/4 of the total number of units shall vest on each anniversary of December 15, 2017. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting. F5 · balance_after: Shares held following the reported transactions include 36,484 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 20:57 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Tax withholdingClass A Common Stock | 4,894 | $60.99 | $298,485.06 |
DisclosureSEC source: 0001209191-17-066573 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,531 F1 · kind: In accordance with Rule 16b-3, shares reported as disposed of were withheld by the Issuer and not issued to the reporting person in order to cover withholding taxes incidental to the vesting of restricted stock units. F2 · balance_after: Shares held following the reported transactions include 22,484 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. F3 · balance_after: Shares include 490 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2017. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-17-057637 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,219 Underlying: Class A Common Stock · 7,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,000 | $60.00 | $420,002.10 |
DisclosureSEC source: 0001209191-17-057637 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F2 · price: This transaction was executed in multiple trades at prices ranging from $60 to $60.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| October 18, 2017 Filed Oct 20, 2017 16:30 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 7,000 | $28.24 | $197,680.00 |
DisclosureSEC source: 0001209191-17-057637 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-17-052989 · doc4.xml · derivative · entry 4 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,219 Underlying: Class A Common Stock · 14,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,000 | $57.50 | $402,500.00 |
DisclosureSEC source: 0001209191-17-052989 · doc4.xml · nonDerivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 7,000 | $55.00 | $385,000.00 |
DisclosureSEC source: 0001209191-17-052989 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,935 F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| September 13, 2017 Filed Sep 15, 2017 16:35 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionClass A Common Stock | 14,000 | $28.24 | $395,360.00 |
DisclosureSEC source: 0001209191-17-052989 · doc4.xml · nonDerivative · entry 1 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,935 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 16:52 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $28.24 | $0.00 |
DisclosureSEC source: 0001209191-17-023887 · doc4.xml · derivative · entry 3 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,219 Underlying: Class A Common Stock · 6,000 shares Expires 2021-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option was granted for a total of 94,219 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vested on the first anniversary of December 15, 2011, the vesting commencement date, and the balance of the shares vested in equal monthly installments over the next 36 months thereafter. Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 16:52 UTC | Dolby Laboratories, Inc. DLB · Entity 2518 | SaleClass A Common Stock | 6,000 | $52.50 | $315,000.00 |
DisclosureSEC source: 0001209191-17-023887 · doc4.xml · nonDerivative · entry 2 SHERMAN MARK ANDREW · CIK 0001256708 · EVP, GEN. COUN. & SECRTY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,935 F1 · balance_after: Shares held following the reported transactions include 31,861 restricted stock units, which are subject to forfeiture until they vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.